THERMO FISHER SCIENTIFIC INC (TN8.DE) Fundamental Analysis & Valuation

FRA:TN8 • US8835561023

Current stock price

426.1 EUR
+1.3 (+0.31%)
Last:

This TN8.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. TN8.DE Profitability Analysis

1.1 Basic Checks

  • TN8 had positive earnings in the past year.
  • TN8 had a positive operating cash flow in the past year.
  • In the past 5 years TN8 has always been profitable.
  • TN8 had a positive operating cash flow in each of the past 5 years.
TN8.DE Yearly Net Income VS EBIT VS OCF VS FCFTN8.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • TN8 has a Return On Assets of 6.08%. This is in the better half of the industry: TN8 outperforms 72.22% of its industry peers.
  • The Return On Equity of TN8 (12.55%) is better than 83.33% of its industry peers.
  • With a Return On Invested Capital value of 6.00%, TN8 perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
  • TN8 had an Average Return On Invested Capital over the past 3 years of 6.18%. This is below the industry average of 9.03%.
Industry RankSector Rank
ROA 6.08%
ROE 12.55%
ROIC 6%
ROA(3y)6.22%
ROA(5y)6.79%
ROE(3y)12.72%
ROE(5y)14.58%
ROIC(3y)6.18%
ROIC(5y)6.93%
TN8.DE Yearly ROA, ROE, ROICTN8.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • With a decent Profit Margin value of 15.05%, TN8 is doing good in the industry, outperforming 72.22% of the companies in the same industry.
  • In the last couple of years the Profit Margin of TN8 has declined.
  • The Operating Margin of TN8 (18.19%) is better than 72.22% of its industry peers.
  • TN8's Operating Margin has declined in the last couple of years.
  • The Gross Margin of TN8 (41.09%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of TN8 has declined.
Industry RankSector Rank
OM 18.19%
PM (TTM) 15.05%
GM 41.09%
OM growth 3Y-1.32%
OM growth 5Y-5.71%
PM growth 3Y-0.93%
PM growth 5Y-5.33%
GM growth 3Y-1.04%
GM growth 5Y-3.78%
TN8.DE Yearly Profit, Operating, Gross MarginsTN8.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. TN8.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TN8 is destroying value.
  • TN8 has less shares outstanding than it did 1 year ago.
  • TN8 has less shares outstanding than it did 5 years ago.
  • TN8 has a worse debt/assets ratio than last year.
TN8.DE Yearly Shares OutstandingTN8.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
TN8.DE Yearly Total Debt VS Total AssetsTN8.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • An Altman-Z score of 3.50 indicates that TN8 is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.50, TN8 is doing good in the industry, outperforming 61.11% of the companies in the same industry.
  • TN8 has a debt to FCF ratio of 6.26. This is a slightly negative value and a sign of low solvency as TN8 would need 6.26 years to pay back of all of its debts.
  • TN8 has a Debt to FCF ratio of 6.26. This is in the better half of the industry: TN8 outperforms 66.67% of its industry peers.
  • A Debt/Equity ratio of 0.67 indicates that TN8 is somewhat dependend on debt financing.
  • TN8's Debt to Equity ratio of 0.67 is in line compared to the rest of the industry. TN8 outperforms 50.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 6.26
Altman-Z 3.5
ROIC/WACC0.59
WACC10.25%
TN8.DE Yearly LT Debt VS Equity VS FCFTN8.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • A Current Ratio of 1.89 indicates that TN8 should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.89, TN8 is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
  • A Quick Ratio of 1.53 indicates that TN8 should not have too much problems paying its short term obligations.
  • The Quick ratio of TN8 (1.53) is better than 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 1.53
TN8.DE Yearly Current Assets VS Current LiabilitesTN8.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. TN8.DE Growth Analysis

3.1 Past

  • TN8 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.62%.
  • Measured over the past 5 years, TN8 shows a small growth in Earnings Per Share. The EPS has been growing by 3.19% on average per year.
  • The Revenue has been growing slightly by 3.91% in the past year.
  • The Revenue has been growing slightly by 6.70% on average over the past years.
EPS 1Y (TTM)4.62%
EPS 3Y-0.53%
EPS 5Y3.19%
EPS Q2Q%7.7%
Revenue 1Y (TTM)3.91%
Revenue growth 3Y-0.27%
Revenue growth 5Y6.7%
Sales Q2Q%7.2%

3.2 Future

  • Based on estimates for the next years, TN8 will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.80% on average per year.
  • The Revenue is expected to grow by 5.26% on average over the next years.
EPS Next Y8.48%
EPS Next 2Y8.83%
EPS Next 3Y9.44%
EPS Next 5Y10.8%
Revenue Next Year5.89%
Revenue Next 2Y5.51%
Revenue Next 3Y5.91%
Revenue Next 5Y5.26%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TN8.DE Yearly Revenue VS EstimatesTN8.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B 40B 50B
TN8.DE Yearly EPS VS EstimatesTN8.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 10 20 30 40

More info and screens

Find the best growth stocksShow best growing peers

3

4. TN8.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 21.82, which indicates a rather expensive current valuation of TN8.
  • The rest of the industry has a similar Price/Earnings ratio as TN8.
  • When comparing the Price/Earnings ratio of TN8 to the average of the S&P500 Index (26.86), we can say TN8 is valued inline with the index average.
  • A Price/Forward Earnings ratio of 20.11 indicates a rather expensive valuation of TN8.
  • TN8's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. TN8 is cheaper than 61.11% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 37.39, TN8 is valued a bit cheaper.
Industry RankSector Rank
PE 21.82
Fwd PE 20.11
TN8.DE Price Earnings VS Forward Price EarningsTN8.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • TN8's Enterprise Value to EBITDA ratio is in line with the industry average.
  • 66.67% of the companies in the same industry are more expensive than TN8, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 29.46
EV/EBITDA 19.69
TN8.DE Per share dataTN8.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.57
PEG (5Y)6.85
EPS Next 2Y8.83%
EPS Next 3Y9.44%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. TN8.DE Dividend Analysis

5.1 Amount

  • TN8 has a yearly dividend return of 0.38%, which is pretty low.
  • TN8's Dividend Yield is comparable with the industry average which is at 0.52.
  • With a Dividend Yield of 0.38, TN8 pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.38%

5.2 History

  • On average, the dividend of TN8 grows each year by 14.67%, which is quite nice.
Dividend Growth(5Y)14.67%
Div Incr Years5
Div Non Decr Years5
TN8.DE Yearly Dividends per shareTN8.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 9.49% of the earnings are spent on dividend by TN8. This is a low number and sustainable payout ratio.
  • TN8's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP9.49%
EPS Next 2Y8.83%
EPS Next 3Y9.44%
TN8.DE Yearly Income VS Free CF VS DividendTN8.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B
TN8.DE Dividend Payout.TN8.DE Dividend Payout, showing the Payout Ratio.TN8.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

TN8.DE Fundamentals: All Metrics, Ratios and Statistics

THERMO FISHER SCIENTIFIC INC

FRA:TN8 (4/10/2026, 7:00:00 PM)

426.1

+1.3 (+0.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners95.33%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap158.29B
Revenue(TTM)44.56B
Net Income(TTM)6.70B
Analysts84
Price Target573.15 (34.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.38%
Yearly Dividend1.43
Dividend Growth(5Y)14.67%
DP9.49%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.64%
Min EPS beat(2)0.91%
Max EPS beat(2)4.37%
EPS beat(4)3
Avg EPS beat(4)1.7%
Min EPS beat(4)-0.07%
Max EPS beat(4)4.37%
EPS beat(8)6
Avg EPS beat(8)2.42%
EPS beat(12)7
Avg EPS beat(12)1.02%
EPS beat(16)11
Avg EPS beat(16)2.83%
Revenue beat(2)2
Avg Revenue beat(2)1.08%
Min Revenue beat(2)0.95%
Max Revenue beat(2)1.21%
Revenue beat(4)4
Avg Revenue beat(4)0.77%
Min Revenue beat(4)0.28%
Max Revenue beat(4)1.21%
Revenue beat(8)6
Avg Revenue beat(8)0.22%
Revenue beat(12)7
Avg Revenue beat(12)-0.27%
Revenue beat(16)11
Avg Revenue beat(16)1.95%
PT rev (1m)0.71%
PT rev (3m)3.75%
EPS NQ rev (1m)-0.24%
EPS NQ rev (3m)-6.14%
EPS NY rev (1m)0.03%
EPS NY rev (3m)-0.22%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-1.52%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.87%
Valuation
Industry RankSector Rank
PE 21.82
Fwd PE 20.11
P/S 4.16
P/FCF 29.46
P/OCF 23.71
P/B 3.47
P/tB N/A
EV/EBITDA 19.69
EPS(TTM)19.53
EY4.58%
EPS(NY)21.19
Fwd EY4.97%
FCF(TTM)14.47
FCFY3.39%
OCF(TTM)17.97
OCFY4.22%
SpS102.42
BVpS122.77
TBVpS-27.11
PEG (NY)2.57
PEG (5Y)6.85
Graham Number232.26
Profitability
Industry RankSector Rank
ROA 6.08%
ROE 12.55%
ROCE 8.52%
ROIC 6%
ROICexc 6.71%
ROICexgc 28.75%
OM 18.19%
PM (TTM) 15.05%
GM 41.09%
FCFM 14.12%
ROA(3y)6.22%
ROA(5y)6.79%
ROE(3y)12.72%
ROE(5y)14.58%
ROIC(3y)6.18%
ROIC(5y)6.93%
ROICexc(3y)6.79%
ROICexc(5y)7.57%
ROICexgc(3y)30.99%
ROICexgc(5y)35.86%
ROCE(3y)8.78%
ROCE(5y)9.93%
ROICexgc growth 3Y-13.91%
ROICexgc growth 5Y-12.87%
ROICexc growth 3Y-6.93%
ROICexc growth 5Y-10.12%
OM growth 3Y-1.32%
OM growth 5Y-5.71%
PM growth 3Y-0.93%
PM growth 5Y-5.33%
GM growth 3Y-1.04%
GM growth 5Y-3.78%
F-Score5
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 6.26
Debt/EBITDA 3.29
Cap/Depr 54.86%
Cap/Sales 3.42%
Interest Coverage 5.03
Cash Conversion 71.82%
Profit Quality 93.87%
Current Ratio 1.89
Quick Ratio 1.53
Altman-Z 3.5
F-Score5
WACC10.25%
ROIC/WACC0.59
Cap/Depr(3y)47.77%
Cap/Depr(5y)61.4%
Cap/Sales(3y)3.38%
Cap/Sales(5y)4.31%
Profit Quality(3y)108.04%
Profit Quality(5y)102.29%
High Growth Momentum
Growth
EPS 1Y (TTM)4.62%
EPS 3Y-0.53%
EPS 5Y3.19%
EPS Q2Q%7.7%
EPS Next Y8.48%
EPS Next 2Y8.83%
EPS Next 3Y9.44%
EPS Next 5Y10.8%
Revenue 1Y (TTM)3.91%
Revenue growth 3Y-0.27%
Revenue growth 5Y6.7%
Sales Q2Q%7.2%
Revenue Next Year5.89%
Revenue Next 2Y5.51%
Revenue Next 3Y5.91%
Revenue Next 5Y5.26%
EBIT growth 1Y5.05%
EBIT growth 3Y-1.59%
EBIT growth 5Y0.61%
EBIT Next Year19.38%
EBIT Next 3Y11.63%
EBIT Next 5Y10.22%
FCF growth 1Y-13.4%
FCF growth 3Y-3.07%
FCF growth 5Y-1.58%
OCF growth 1Y-9.8%
OCF growth 3Y-5.12%
OCF growth 5Y-1.16%

THERMO FISHER SCIENTIFIC INC / TN8.DE Fundamental Analysis FAQ

What is the fundamental rating for TN8 stock?

ChartMill assigns a fundamental rating of 4 / 10 to TN8.DE.


What is the valuation status for TN8 stock?

ChartMill assigns a valuation rating of 3 / 10 to THERMO FISHER SCIENTIFIC INC (TN8.DE). This can be considered as Overvalued.


How profitable is THERMO FISHER SCIENTIFIC INC (TN8.DE) stock?

THERMO FISHER SCIENTIFIC INC (TN8.DE) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for TN8 stock?

The Price/Earnings (PE) ratio for THERMO FISHER SCIENTIFIC INC (TN8.DE) is 21.82 and the Price/Book (PB) ratio is 3.47.


What is the earnings growth outlook for THERMO FISHER SCIENTIFIC INC?

The Earnings per Share (EPS) of THERMO FISHER SCIENTIFIC INC (TN8.DE) is expected to grow by 8.48% in the next year.